HOOK Rasio cepet HOOKIPA Pharma, Inc.

HOOKIPA Pharma Inc. (HOOK) leverages unique Vaxwave platforms for targeted oncology treatment, creating a dependency among pharma behemoths on its research. Production safety is ensured through strict bio-waste control and laboratory filtration. This chart confirms the market price on GURU.Markets is 0.00, while quotes are pressured by the risks of failed new drug trials and the need for regular capital raises through equity issuances.

The metric is calculated by dividing the sum of cash and accounts receivable by current liabilities. This filter excludes slow-moving inventories to assess the company's ability to settle debts instantaneously. For HOOKIPA Pharma Inc. (HOOK), this is critical, as geopolitical disruptions in reagent logistics could freeze research and impair the value of warehouse stocks. Monitoring the liquidity ratio excluding illiquid assets allows for the timely identification of cash gap risks.